{"schema":"hottub-news/story/v1","story":"st_zcj3kdzmhnc3skkuazaa","title":"Analyzing Fate Therapeutics (NASDAQ:FATE) and Syndax Pharmaceuticals (NASDAQ:SNDX)","title_en":null,"outlets":1,"brief":null,"page":"https://hottub.news/stories/analyzing-fate-therapeutics-nasdaq-fate-and-syndax-pharmaceuticals-zcj3kdzmhn","count":1,"items":[{"id":"n_zcj3kdzmhnc3skkuazaa","seq":1535615,"kind":"article","title":"Analyzing Fate Therapeutics (NASDAQ:FATE) and Syndax Pharmaceuticals (NASDAQ:SNDX)","url":"https://www.themarketsdaily.com/2026/10/03/analyzing-fate-therapeutics-nasdaqfate-and-syndax-pharmaceuticals-nasdaqsndx.html","published":"2026-10-03T13:06:23Z","seen":"2026-10-03T13:06:23Z","lang":"en","source":{"id":"themarketsdaily.com","name":"themarketsdaily.com","domain":"themarketsdaily.com"},"via":"gdelt-gkg-english","topics":["economy","business","health"],"authors":["Tristan Rich"],"entities":[{"id":"Q30287119","name":"Fate Therapeutics","type":"org"},{"id":"Q112085354","name":"Syndax Pharmaceuticals","type":"org"}],"story":"st_zcj3kdzmhnc3skkuazaa","category":"economy-business","category_p":0.5899999737739563,"sentiment":"neutral","tone":0.46000000834465027,"political":0.019999999552965164}]}